BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38303840)

  • 1. Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents.
    Otsuru M; Fujiki Y; Soutome S; Nakamura N; Miyoshi T; Naruse T; Ohnuma M; Hotokezaka Y; Rokutanda S; Umeda M
    J Dent Sci; 2024 Jan; 19(1):203-210. PubMed ID: 38303840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study.
    Soutome S; Otsuru M; Murata M; Morishita K; Omori K; Suyama K; Hayashida S; Umeda M; Saito T
    Support Care Cancer; 2022 Sep; 30(9):7241-7248. PubMed ID: 35587291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients.
    Soutome S; Otsuru M; Hayashida S; Murata M; Yanamoto S; Sawada S; Kojima Y; Funahara M; Iwai H; Umeda M; Saito T
    Sci Rep; 2021 Aug; 11(1):17226. PubMed ID: 34446755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
    Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
    Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor Radiographic Findings in Patients With Medication-Related Osteonecrosis of the Jaw.
    Kajihara R; Kondo E; Fukuda H; Sakai H; Koike T; Kurita H
    J Oral Maxillofac Surg; 2024 Apr; ():. PubMed ID: 38750657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction.
    Moreno-Rabié C; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; Gielen E; Van den Wyngaert T; Jacobs R
    Oral Dis; 2024 Apr; 30(3):1632-1642. PubMed ID: 36620873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?
    Klingelhöffer C; Klingelhöffer M; Müller S; Ettl T; Wahlmann U
    Dentomaxillofac Radiol; 2016; 45(5):20160065. PubMed ID: 27213837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction.
    Moreno-Rabié C; Lapauw L; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; van den Wyngaert T; Jacobs R
    Sci Rep; 2022 Jul; 12(1):11280. PubMed ID: 35789184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
    Moreno-Rabié C; Fontenele RC; Oliveira-Santos N; Nogueira-Reis F; Van den Wyngaert T; Jacobs R
    Osteoporos Int; 2024 May; ():. PubMed ID: 38767743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do some extraction sites develop medication-related osteonecrosis of the jaw and others do not? A within-patient study assessing radiographic predictors.
    Gaêta-Araujo H; Ferreira Leite A; de Faria Vasconcelos K; Coropciuc R; Politis C; Jacobs R; Oliveira-Santos C
    Int J Oral Implantol (Berl); 2021 Mar; 14(1):87-98. PubMed ID: 34006074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.
    Muttanahally KS; Tadinada A
    Cureus; 2023 Aug; 15(8):e42830. PubMed ID: 37664344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiresorptive agent-related osteonecrosis of the jaw risk in cancer patients before bone-modifying agent therapy: A retrospective study of 511 patients.
    Kanno C; Kojima M; Tezuka Y; Yaginuma S; Kanaya Y; Kaneko T
    Bone; 2023 Dec; 177():116892. PubMed ID: 37689127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Medication-Related Osteonecrosis of the Jaw After Extraction of Teeth With Experimental Periapical Disease.
    Hadaya D; Soundia A; Gkouveris I; Dry SM; Aghaloo TL; Tetradis S
    J Oral Maxillofac Surg; 2019 Jan; 77(1):71-86. PubMed ID: 30218655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
    Neal TW; Schlieve T
    J Oral Maxillofac Surg; 2022 Oct; 80(10):1686-1690. PubMed ID: 35931181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
    Ueda N; Nakashima C; Aoki K; Shimotsuji H; Nakaue K; Yoshioka H; Kurokawa S; Imai Y; Kirita T
    Clin Oral Investig; 2021 May; 25(5):3087-3093. PubMed ID: 33057886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study.
    Seki K; Kaneko T; Kamimoto A; Wada M; Takeuchi Y; Furuchi M; Iinuma T
    J Dent Sci; 2022 Oct; 17(4):1619-1625. PubMed ID: 36299343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.
    Moreno Rabie C; Cavalcante Fontenele R; Oliveira Santos N; Nogueira Reis F; Van den Wyngaert T; Jacobs R
    Dentomaxillofac Radiol; 2023 Nov; 52(8):20230238. PubMed ID: 37874081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Medication-Related Osteonecrosis of the Jaw: Odontogenic Infection-Preceding Type and Osteonecrosis-Preceding Type.
    Sakamoto Y; Sawada S; Kojima Y
    Cureus; 2024 May; 16(5):e60223. PubMed ID: 38868238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.